Literature DB >> 3013314

Beta-adrenergic stimulation enhances translocation, processing and synthesis of lipoprotein lipase in rat heart cells.

G Friedman, T Chajek-Shaul, O Stein, L Noe, J Etienne, Y Stein.   

Abstract

Cells isolated from newborn rat hearts were cultured for 10-14 days, and lipoprotein lipase activity was present in an intracellular and heparin-releasable pool. Treatment of the cultures with 10(-7) M isoproterenol for 3 min resulted in a 3-fold increase in heparin-releasable lipoprotein lipase and a concomitant decrease in residual cellular enzyme activity. Similar results were obtained by treatment with dibutyryl cAMP. Treatment with isoproterenol or dibutyryl cAMP for 2 h affected glycosylation of immunoadsorbable lipoprotein lipase, so that the ratio of [3H]galactose to [14C]mannose in the heparin-releasable enzyme increased from 3.8 (control) to 13.0 (isoproterenol-treated). The change in the ratio of the sugars in the cellular fraction of the enzyme was from 3.1 to 9.9. 2 h treatment with isoproterenol did not enhance new enzyme synthesis, as determined by incorporation of [3H]leucine into immunoadsorbable lipoprotein lipase. 24 h after addition of either isoproterenol or dibutyryl cAMP to the culture medium, stimulation of enzyme synthesis was demonstrated. The present results permit three effects of isoproterenol on lipoprotein lipase to be distinguished: stimulation of translocation from a cellular to heparin-releasable pool; enhanced processing of mannose residues and terminal glycosylation; stimulation of synthesis of enzyme protein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013314     DOI: 10.1016/0005-2760(86)90125-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Long term incubation of cardiac myocytes with oleic acid and very-low density lipoprotein reduces heparin-releasable lipoprotein lipase activity.

Authors:  B Rodrigues; M R Spooner; D L Severson
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

2.  Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity.

Authors:  D L Severson; R Carroll; A Kryski; I Ramírez
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

3.  Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat.

Authors:  I Gouni-Berthold; K Oka; H K Berthold; L Chan
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

4.  Lipoprotein lipase activity in neonatal-rat liver cell types.

Authors:  F Burgaya; J Peinado; S Vilaró; M Llobera; I Ramírez
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

5.  Lipoprotein lipase, hepatic lipase, and carnitine in premature infants.

Authors:  L M Rovamo; E A Nikkilä; K O Raivio
Journal:  Arch Dis Child       Date:  1988-02       Impact factor: 3.791

6.  Two different mechanisms are involved in nutritional regulation of lipoprotein lipase in guinea-pig adipose tissue.

Authors:  H Semb; T Olivecrona
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

7.  Treatment of cardiac myocytes with 8-(4-chlorophenylthio)-adenosine 3',5'-cyclic monophosphate, forskolin or cholera toxin does not stimulate cellular or heparin-releasable lipoprotein lipase activities.

Authors:  R Carroll; A Juhasz; D L Severson
Journal:  Biochem J       Date:  1990-09-01       Impact factor: 3.857

8.  Long-term effect of cyclic AMP on N-glycosylation is caused by an increase in the activity of the cis-prenyltransferase.

Authors:  M Konrad; W E Merz
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 9.  A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.

Authors:  M J Kendall; I Rajman
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

10.  Regulation of lipoprotein lipase activity and mRNA in the mammary gland of the lactating mouse.

Authors:  D R Jensen; S Gavigan; V Sawicki; D L Witsell; R H Eckel; M C Neville
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.